MEDS will publish its 2025 year-end report on February 10, 2026, at 07:30 CET. A webcast presentation will be held for analysts, media, and investors at 09:30 CET the same day.

The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.

The presentation will be conducted in English and broadcast live online. Please email ir@meds.se  to receive a link to the live presentation (at latest 09:00 CET on 10th of February).

A recorded version of the presentation will be available later at: Rapporter och presentationer | MEDS Investor Relations

Schedule for the 10th of February:

  • 07:30 CET – Publication of the Q4 report
  • 9:30 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola


For further information, please contact:
Frida Benno Hjerpe
MEDS Press & Investor Relations
E-mail: press@meds.se
Web: https://corporate.meds.se/

About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.

Certified advisor is FNCA.

Attachments

Invitation to presentation of MEDS 2025 year-end report on February 10, 2026

Läs mer på MFN

Ämnen i artikeln


Meds Apotek

Senast

44,20

1 dag %

−2,64%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån